Pharma Foods International Co., Ltd. (2929.T)
JPY 917.0
(1.1%)
JPY 917.0
(1.1%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 43.63 Billion JPY | -15.54% |
| 2023 | 51.66 Billion JPY | 9.87% |
| 2022 | 47.02 Billion JPY | 38.11% |
| 2021 | 34.04 Billion JPY | 197.76% |
| 2020 | 11.43 Billion JPY | 43.65% |
| 2019 | 7.96 Billion JPY | 31.47% |
| 2018 | 6.05 Billion JPY | 140.42% |
| 2017 | 2.51 Billion JPY | 35.41% |
| 2016 | 1.85 Billion JPY | 19.11% |
| 2015 | 1.56 Billion JPY | 94.66% |
| 2014 | 802.17 Million JPY | 69.67% |
| 2013 | 472.79 Million JPY | 15.69% |
| 2012 | 408.69 Million JPY | 8.2% |
| 2011 | 377.7 Million JPY | -12.49% |
| 2010 | 431.63 Million JPY | 1.84% |
| 2009 | 423.82 Million JPY | -29.69% |
| 2008 | 602.81 Million JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 12.11 Billion JPY | 10.15% |
| 2024 Q4 | 9.6 Billion JPY | -8.12% |
| 2024 Q2 | 11.4 Billion JPY | -5.82% |
| 2024 Q3 | 10.45 Billion JPY | -8.39% |
| 2023 FY | 51.66 Billion JPY | 9.87% |
| 2023 Q2 | 13.25 Billion JPY | -17.27% |
| 2023 Q4 | 10.99 Billion JPY | -3.53% |
| 2023 Q1 | 16.01 Billion JPY | 25.75% |
| 2023 Q3 | 11.4 Billion JPY | -13.97% |
| 2022 Q4 | 12.73 Billion JPY | -4.14% |
| 2022 FY | 47.02 Billion JPY | 38.11% |
| 2022 Q3 | 13.28 Billion JPY | 11.76% |
| 2022 Q2 | 11.89 Billion JPY | 30.52% |
| 2022 Q1 | 9.11 Billion JPY | 13.93% |
| 2021 Q2 | 8.89 Billion JPY | 5.0% |
| 2021 FY | 34.04 Billion JPY | 197.76% |
| 2021 Q4 | 7.99 Billion JPY | -7.88% |
| 2021 Q3 | 8.67 Billion JPY | -2.46% |
| 2021 Q1 | 8.47 Billion JPY | 259.14% |
| 2020 FY | 11.43 Billion JPY | 43.65% |
| 2020 Q4 | 2.35 Billion JPY | -0.4% |
| 2020 Q3 | 2.36 Billion JPY | -32.92% |
| 2020 Q1 | 3.17 Billion JPY | 130.39% |
| 2020 Q2 | 3.53 Billion JPY | 11.27% |
| 2019 Q2 | 2.04 Billion JPY | -18.24% |
| 2019 FY | 7.96 Billion JPY | 31.47% |
| 2019 Q4 | 1.37 Billion JPY | -32.56% |
| 2019 Q1 | 2.49 Billion JPY | 137.43% |
| 2019 Q3 | 2.04 Billion JPY | 0.05% |
| 2018 Q4 | 1.05 Billion JPY | -46.85% |
| 2018 Q2 | 1.62 Billion JPY | 16.8% |
| 2018 Q1 | 1.39 Billion JPY | 245.3% |
| 2018 FY | 6.05 Billion JPY | 140.42% |
| 2018 Q3 | 1.97 Billion JPY | 21.47% |
| 2017 Q3 | 474.17 Million JPY | -42.43% |
| 2017 FY | 2.51 Billion JPY | 35.41% |
| 2017 Q4 | 403.97 Million JPY | -14.8% |
| 2017 Q2 | 823.58 Million JPY | 0.84% |
| 2017 Q1 | 816.73 Million JPY | 591.8% |
| 2016 FY | 1.85 Billion JPY | 19.11% |
| 2016 Q2 | 579.1 Million JPY | -22.95% |
| 2016 Q1 | 751.57 Million JPY | 55.0% |
| 2016 Q3 | 411.14 Million JPY | -29.0% |
| 2016 Q4 | 118.05 Million JPY | -71.29% |
| 2015 Q3 | 411.85 Million JPY | 21.19% |
| 2015 Q2 | 339.84 Million JPY | 4.59% |
| 2015 Q1 | 324.92 Million JPY | 55.9% |
| 2015 FY | 1.56 Billion JPY | 94.66% |
| 2015 Q4 | 484.88 Million JPY | 17.73% |
| 2014 Q4 | 208.42 Million JPY | -14.96% |
| 2014 Q1 | 130.45 Million JPY | -19.41% |
| 2014 FY | 802.17 Million JPY | 69.67% |
| 2014 Q2 | 218.2 Million JPY | 67.27% |
| 2014 Q3 | 245.09 Million JPY | 12.33% |
| 2013 FY | 472.79 Million JPY | 15.69% |
| 2013 Q1 | 122.54 Million JPY | -2.41% |
| 2013 Q2 | 89.61 Million JPY | -26.87% |
| 2013 Q3 | 98.77 Million JPY | 10.22% |
| 2013 Q4 | 161.86 Million JPY | 63.88% |
| 2012 Q4 | 125.57 Million JPY | 33.0% |
| 2012 FY | 408.69 Million JPY | 8.2% |
| 2012 Q2 | 89.18 Million JPY | -10.38% |
| 2012 Q3 | 94.41 Million JPY | 5.86% |
| 2012 Q1 | 99.52 Million JPY | 6.51% |
| 2011 Q2 | 89.87 Million JPY | -8.42% |
| 2011 FY | 377.7 Million JPY | -12.49% |
| 2011 Q4 | 93.44 Million JPY | -4.83% |
| 2011 Q3 | 98.18 Million JPY | 9.26% |
| 2011 Q1 | 98.12 Million JPY | -12.9% |
| 2010 Q2 | 108.25 Million JPY | -4.32% |
| 2010 FY | 431.63 Million JPY | 1.84% |
| 2010 Q1 | 113.13 Million JPY | 1.66% |
| 2010 Q4 | 112.65 Million JPY | 6.03% |
| 2010 Q3 | 106.24 Million JPY | -1.85% |
| 2009 Q4 | 111.29 Million JPY | 8.18% |
| 2009 Q3 | 102.87 Million JPY | -6.81% |
| 2009 Q1 | 102.99 Million JPY | 0.0% |
| 2009 FY | 423.82 Million JPY | -29.69% |
| 2009 Q2 | 110.39 Million JPY | 7.19% |
| 2008 FY | 602.81 Million JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.333% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 91.951% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 77.918% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1067.955% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 33.509% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -50.345% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 91.813% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -726.183% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 33.683% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 5.68% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -277.729% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -430.114% |
| Tsumura & Co. | 48.8 Billion JPY | 10.576% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -30.954% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -123.366% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 31.532% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -244.782% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -7.845% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 3.868% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -949.771% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -634.045% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -735.567% |
| MedRx Co., Ltd | 959 Million JPY | -4450.469% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -1418.55% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -2856.572% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1740.792% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -80.588% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -23.159% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -5835.817% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 56.281% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1833.25% |